glp 1 agonist companies Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating GLP-1 Receptor Agonist Companies and
Description
They are unregulated, have not been reviewed by the FDA for safety or effectiveness, and are not available in pharmacies

doi:10.1016/S0140-6736(18)32260-8 32

This draws air into the syringe

Looking Forward: The Future GLP-1 Ecosystem As we look ahead, several developments will likely shape the evolving GLP-1 landscape: Technological Integration : The combination of GLP-1 therapies with continuous glucose monitors and other wearable devices will enable increasingly personalized treatment approaches

GLP-1 agonists are approved for the treatment of diabetes and for obesity
